Press Releases

GRAIL Announces Appointment of Hal Barron and Hans Bishop to its Board of Directors

August 9 2018

GRAIL Announces Appointment of Key Executives as Company Makes Continued Progress in Development of Early Detection Products

July 9 2018

GRAIL Announces Data on Detection of Early-Stage Lung Cancers

June 2 2018

GRAIL Announces $300 Million Raised in Oversubscribed Series C Financing

May 21 2018

GRAIL to Present New Data from Circulating Cell-free Genome Atlas (CCGA) Study at 2018 American Society of Clinical Oncology Annual Meeting

May 16 2018

GRAIL Announces Data from Prototype Blood Tests for Early Cancer Detection

April 17 2018

GRAIL Announces Appointment of Jennifer Cook as Chief Executive Officer

December 14 2017

GRAIL Appoints Chairman Bill Rastetter to Chief Executive Officer

August 2 2017

GRAIL Announces Data From Early Research Analyzing its High-Intensity Sequencing Approach

June 3 2017

GRAIL and Cirina Combine to Create Global Company Focused on Early Detection of Cancer

May 31 2017

GRAIL Announces Board of Directors Appointments

May 4 2017

GRAIL Initiates the STRIVE Study to Advance Development of Blood Tests to Detect Cancer Early

April 20 2017

GRAIL Closes Over $900 Million Initial Investment in Series B Financing to Develop Blood Tests to Detect Cancer Early

March 1 2017

GRAIL Plans to Raise in Excess of $1B in Series B Funding

January 5 2017

GRAIL Announces Circulating Cell-free Genome Atlas (CCGA) Study as Foundation for Development of Blood Test to Detect Cancer Early

December 1 2016

GRAIL Hires Google Executive Jeff Huber as CEO to Lead Development for Early Cancer Detection

February 10 2016

Illumina Forms New Company to Enable Early Cancer Detection via Blood-Based Screening

January 10 2016

Media Kit

Stay in the know